Global Blood Therapeutics, Inc.
GBT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $685 | $495 | $302 | $275 |
| Short-Term Investments | $0 | $66 | $308 | $202 |
| Receivables | $29 | $18 | $3 | $0 |
| Inventory | $58 | $40 | $1 | $0 |
| Other Curr. Assets | $30 | $14 | $14 | $8 |
| Total Curr. Assets | $802 | $632 | $628 | $486 |
| Property Plant & Equip (Net) | $83 | $89 | $80 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $50 | $0 | $85 | $114 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $3 | $3 | $3 |
| Total NC Assets | $137 | $92 | $168 | $132 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $939 | $724 | $796 | $618 |
| Liabilities | – | – | – | – |
| Payables | $15 | $19 | $11 | $6 |
| Short-Term Debt | $6 | $5 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $67 | $55 | $59 | $28 |
| Total Curr. Liab. | $88 | $79 | $71 | $34 |
| LT Debt | $654 | $149 | $74 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $80 | $72 | $11 |
| Total NC Liab. | $655 | $229 | $146 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $743 | $308 | $217 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,290 | -$986 | -$739 | -$472 |
| AOCI | $0 | $0 | $1 | -$0 |
| Other Equity | $1,486 | $1,402 | $1,317 | $1,045 |
| Total Equity | $196 | $416 | $579 | $573 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $939 | $724 | $796 | $618 |
| Net Debt | -$25 | -$341 | -$227 | -$275 |